OB/GYN Clinical Alert – February 1, 2009
February 1, 2009
View Issues
-
Determining the Optimal Time to Deliver
The stars were aligned when four papers appeared in two obstetrical journals within a month of each other dealing with the optimal time in gestation to deliver. -
Hyperinsulinemia a Risk Factor for Breast Cancer in Non-HT Users
The above study involved a detailed analysis of data obtained in the observational arm of the Women's Health Initiative. As a rationale, the authors note that obesity is a well-established risk factor for breast cancer. -
Ginkgo biloba for Dementia Prevention
A randomized, double-blind, placebo-controlled trial comparing Ginkgo biloba with placebo for the prevention of dementia enrolled 3069 elderly individuals (older than age 75) in 5 academic centers in the United States. -
Teenagers, Bone Loss, and Long-term Depot Medroxyprogesterone Acetate Use (24 Months)
Cromer et al performed a 24-month observational, prospective cohort study of adolescents in the Midwest using depot medroxyprogesterone acetate (DMPA), oral contraceptives (OCs), or nothing. DEXA scans were performed at baseline and 6-month intervals. -
Bazedoxifene Prevents Fractures
A 3-year randomized, double-blind clinical trial in 206 sites throughout the world compared bazedoxifene (20 mg or 40 mg) and raloxifene (60 mg) with placebo. -
Pharmacology Watch: How Best to Control Hypertension?
In this issue: Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions. -
Clinical Briefs in Primary Care supplement